HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Madhav Bhatia Selected Research

L 703606

11/2010Substance P upregulates cyclooxygenase-2 and prostaglandin E metabolite by activating ERK1/2 and NF-kappaB in a mouse model of burn-induced remote acute lung injury.
6/2008The neuropeptide substance P is a critical mediator of burn-induced acute lung injury.
9/2007Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Madhav Bhatia Research Topics

Disease

47Pancreatitis
11/2021 - 01/2002
41Inflammation (Inflammations)
10/2021 - 06/2005
30Sepsis (Septicemia)
03/2022 - 03/2006
24Lung Injury
01/2016 - 05/2003
11Neurogenic Inflammation
11/2011 - 05/2003
9Pneumonia (Pneumonitis)
06/2008 - 07/2005
6Edema (Dropsy)
04/2019 - 09/2010
6Necrosis
10/2017 - 02/2004
6Burns
01/2015 - 06/2008
5Acute Lung Injury
05/2012 - 06/2008
5Shock
06/2008 - 12/2004
4Multiple Organ Failure (MODS)
01/2021 - 01/2009
4Endotoxemia
09/2010 - 10/2005
3Hyperamylasemia
05/2009 - 04/2005
2Visceral Leishmaniasis (Kala Azar)
01/2022 - 10/2017
2Infections
12/2021 - 01/2014
2Neoplasms (Cancer)
05/2016 - 01/2015
2Asthma (Bronchial Asthma)
01/2014 - 05/2010
1Aspergillosis
05/2022
1Dysbiosis
01/2021
1Critical Illness (Critically Ill)
01/2021
1Myocardial Infarction
06/2020
1Infarction (Infarctions)
06/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2018
1Hypertrophy
01/2018

Drug/Important Bio-Agent (IBA)

37Hydrogen Sulfide (Sulfide, Hydrogen)IBA
11/2021 - 04/2005
35Substance PIBA
11/2021 - 05/2003
29ChemokinesIBA
01/2022 - 01/2002
23CeruletideIBA
05/2016 - 10/2002
17Peroxidase (Myeloperoxidase)IBA
04/2019 - 02/2005
15CytokinesIBA
01/2018 - 10/2002
15sodium bisulfide (NaHS)IBA
04/2011 - 07/2005
13NeuropeptidesIBA
11/2021 - 09/2005
13preprotachykininIBA
06/2019 - 05/2003
13Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
06/2019 - 02/2005
11propargylglycineIBA
01/2011 - 12/2004
8AmylasesFDA Link
04/2019 - 02/2005
7Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA
06/2019 - 12/2004
6EnzymesIBA
06/2019 - 10/2005
6Messenger RNA (mRNA)IBA
09/2010 - 02/2006
5GasotransmittersIBA
03/2022 - 04/2008
5Interleukin-6 (Interleukin 6)IBA
10/2017 - 02/2004
5LipopolysaccharidesIBA
09/2017 - 07/2005
5Biological ProductsIBA
04/2011 - 01/2008
4NF-kappa B (NF-kB)IBA
11/2010 - 04/2007
4salicylhydroxamic acid (SHAM)IBA
09/2010 - 06/2006
4Indicators and Reagents (Reagents)IBA
06/2008 - 10/2005
4CXC ChemokinesIBA
05/2008 - 10/2002
3CystathionineIBA
06/2020 - 11/2013
3LyasesIBA
06/2020 - 11/2013
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2017 - 12/2006
3capsazepineIBA
01/2011 - 11/2006
3L 703606IBA
11/2010 - 09/2007
33- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
11/2010 - 04/2007
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
10/2010 - 05/2009
3Neurokinin-1 Receptor AntagonistsIBA
09/2010 - 09/2007
3Interleukin-10 (Interleukin 10)IBA
01/2009 - 02/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2008 - 02/2004
3CC ChemokinesIBA
05/2008 - 10/2002
3HydrogenIBA
04/2008 - 12/2004
3Pharmaceutical PreparationsIBA
01/2008 - 07/2005
2Monoclonal AntibodiesIBA
05/2022 - 05/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 02/2004
2Lipase (Acid Lipase)FDA Link
04/2019 - 10/2005
2Peptides (Polypeptides)IBA
11/2015 - 01/2014
2ElementsIBA
01/2015 - 01/2011
2Cysteine (L-Cysteine)FDA Link
01/2012 - 12/2004
2ProstaglandinsIBA
11/2011 - 11/2010
2Prostaglandins EIBA
11/2011 - 11/2010
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2011 - 11/2010
2parecoxibIBA
11/2011 - 11/2010
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2011 - 11/2010
22- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
11/2010 - 09/2008
2SecretagoguesIBA
03/2010 - 12/2006
2Chemotactic FactorsIBA
03/2010 - 10/2002
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2009 - 05/2007
2Proteins (Proteins, Gene)FDA Link
06/2008 - 10/2007
2bindaritIBA
06/2008 - 06/2005
2Alanine Transaminase (SGPT)IBA
02/2008 - 10/2005
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2008 - 10/2005
2Neurokinin AIBA
02/2008 - 03/2006
2InterleukinsIBA
05/2007 - 02/2004
21-cyano-2-hydroxy-3-buteneIBA
05/2007 - 07/2006
2CCR1 ReceptorsIBA
04/2007 - 03/2007
2BX 471IBA
04/2007 - 03/2007
2CP 96345IBA
11/2006 - 02/2005
2LigandsIBA
10/2005 - 02/2005
2Monocyte Chemoattractant ProteinsIBA
06/2005 - 10/2002
1GasesIBA
03/2022
1AntigensIBA
12/2021
1SolutionsIBA
01/2021
1PrebioticsIBA
01/2021
1GYY 4137IBA
06/2020
1LactoseFDA LinkGeneric
01/2018

Therapy/Procedure

21Ligation
06/2020 - 03/2006
20Punctures
06/2019 - 03/2006
7Injections
05/2016 - 02/2005
5Therapeutics
01/2021 - 01/2007
5Intraperitoneal Injections
10/2010 - 10/2002
1Fecal Microbiota Transplantation
01/2021